|
NL7210355A
(enExample)
|
1971-08-03 |
1973-02-06 |
|
|
|
GB1447456A
(en)
|
1973-06-20 |
1976-08-25 |
Teijin Ltd |
Process for preparing desmosterols
|
|
GB8607294D0
(en)
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
DE3823318A1
(de)
|
1988-07-09 |
1990-02-22 |
Bayer Ag |
(hetero)aryloxynaphthaline mit ueber schwefel gebundenen substituenten
|
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
|
DK0567586T3
(da)
|
1991-01-16 |
1995-12-04 |
Schering Corp |
Anvendelse af interleukin-10 ved adoptiv immunterapi af cancer
|
|
TW263508B
(enExample)
|
1991-02-12 |
1995-11-21 |
Pfizer |
|
|
US5229109A
(en)
|
1992-04-14 |
1993-07-20 |
Board Of Regents, The University Of Texas System |
Low toxicity interleukin-2 analogues for use in immunotherapy
|
|
JP3414433B2
(ja)
|
1993-03-01 |
2003-06-09 |
日本化薬株式会社 |
電子写真用トナー
|
|
DE19523446A1
(de)
|
1995-06-28 |
1997-01-02 |
Bayer Ag |
Benzotriazole
|
|
AU6490396A
(en)
|
1995-07-14 |
1997-02-18 |
Smithkline Beecham Corporation |
Substituted-pent-4-ynoic acids
|
|
JPH11514969A
(ja)
|
1995-08-10 |
1999-12-21 |
バイエル・アクチエンゲゼルシヤフト |
ハロベンゾイミダゾール類および殺微生物剤としてのそれらの使用
|
|
EP0882718B1
(en)
|
1995-12-28 |
2005-08-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
|
CA2258728C
(en)
|
1996-06-19 |
2011-09-27 |
Rhone Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
DE69728986T2
(de)
*
|
1996-06-21 |
2005-04-07 |
Allergan, Inc., Irvine |
Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
|
|
HUP9903330A2
(hu)
|
1996-11-19 |
2000-03-28 |
Amgen Inc. |
Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények
|
|
US6392010B1
(en)
|
1996-12-19 |
2002-05-21 |
Aventis Pharmaceuticals Inc. |
Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds
|
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
JP4327915B2
(ja)
|
1998-03-30 |
2009-09-09 |
株式会社デ・ウエスタン・セラピテクス研究所 |
スルフォンアミド誘導体
|
|
CZ2001959A3
(cs)
|
1998-09-18 |
2001-12-12 |
Basf Aktiengesellschaft |
4-Aminopyrrolopyrimidiny jako inhibitory kinasy
|
|
US6348032B1
(en)
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
|
WO2001012600A1
(en)
|
1999-08-12 |
2001-02-22 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
ES2270868T3
(es)
|
1999-08-13 |
2007-04-16 |
Biogen Idec Ma Inc. |
Inhibidores de la adhesion celular.
|
|
US7115750B1
(en)
|
1999-09-20 |
2006-10-03 |
Takeda Pharmaceutical Company Limited |
Melanin concentrating hormone antagonist
|
|
AU2001285018A1
(en)
|
2000-08-17 |
2002-02-25 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
|
|
HUP0302352A3
(en)
|
2000-11-09 |
2007-03-28 |
Neopharm |
Sn-38 lipid complexes and methods of use
|
|
TWI239942B
(en)
|
2001-06-11 |
2005-09-21 |
Dainippon Pharmaceutical Co |
N-arylphenylacetamide derivative and pharmaceutical composition containing the same
|
|
MXPA04001014A
(es)
|
2001-08-03 |
2004-05-27 |
Schering Corp |
Novedosos inhibidores de la gama secretasa.
|
|
DE60232981D1
(de)
|
2001-08-17 |
2009-08-27 |
Sankyo Agro Co Ltd |
3-phenoxy-4-pyridazinolderivat und dieses enthaltende herbizide zusammensetzung
|
|
AU2003274463B2
(en)
|
2002-06-10 |
2009-10-29 |
University Of Rochester |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
US6894061B2
(en)
|
2002-12-04 |
2005-05-17 |
Wyeth |
Substituted dihydrophenanthridinesulfonamides
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
WO2004056820A1
(en)
*
|
2002-12-20 |
2004-07-08 |
Warner-Lambert Company Llc |
Benzoxazines and derivatives thereof as inhibitors of pi3ks
|
|
JP4601038B2
(ja)
|
2003-03-26 |
2010-12-22 |
第一三共株式会社 |
インドリルマレイミド類
|
|
US20080199486A1
(en)
|
2003-05-12 |
2008-08-21 |
Yair Argon |
Grp94-based compositions and methods of use thereof
|
|
NZ546611A
(en)
|
2003-09-18 |
2010-02-26 |
Conforma Therapeutics Corp |
Novel heterocyclic compounds as HSP90-inhibitors
|
|
AU2004275444A1
(en)
|
2003-09-26 |
2005-04-07 |
Forbes Medi-Tech Inc. |
Method of inhibiting the expression of a multi-drug resistance genes and inhibiting the production of proteins resulting from the expression of such genes thereby enhancing the effectiveness of chemotherapeutic agents to treat cancers
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2005033048A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Wnt pathway antagonists
|
|
SE0302760D0
(sv)
|
2003-10-20 |
2003-10-20 |
Biovitrum Ab |
New compounds
|
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
AU2004299201B2
(en)
|
2003-12-09 |
2009-12-03 |
F. Hoffmann-La Roche Ag |
Benzoxazine derivatives and uses thereof
|
|
JP2007517052A
(ja)
|
2003-12-23 |
2007-06-28 |
ノバルティス アクチエンゲゼルシャフト |
二環式ヘテロ環式ｐ−３８キナーゼ阻害剤
|
|
WO2005084208A2
(en)
|
2004-02-27 |
2005-09-15 |
New York University |
A novel class of sterol ligands and their uses in regulation of cholesterol and gene expression
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
EP1768662A2
(en)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
EP1771204A4
(en)
|
2004-07-01 |
2008-08-13 |
Univ New York |
COMPOSITIONS AND METHOD FOR MODULATING ROR-GAMMA-T
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
US7304073B2
(en)
|
2004-08-20 |
2007-12-04 |
Wyeth |
Method of treating myocardial ischemia-reperfusion injury using NF-kB inhibitors
|
|
US7652043B2
(en)
|
2004-09-29 |
2010-01-26 |
The Johns Hopkins University |
WNT pathway antagonists
|
|
PT1809321E
(pt)
|
2004-10-08 |
2012-05-17 |
Us Gov Health & Human Serv |
Imunoterapia adotiva com sobrevivência aumentada de linfócitos
|
|
EP1814580B1
(en)
|
2004-11-24 |
2016-08-10 |
Fred Hutchinson Cancer Research Center |
Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens
|
|
AR051780A1
(es)
|
2004-11-29 |
2007-02-07 |
Japan Tobacco Inc |
Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
|
|
GB0514911D0
(en)
|
2005-07-20 |
2005-08-24 |
Univ Birmingham |
T cell memory assay
|
|
RU2008110908A
(ru)
|
2005-08-25 |
2009-09-27 |
Шеринг Корпорейшн (US) |
Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
JP2009509928A
(ja)
|
2005-09-01 |
2009-03-12 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
カリウムチャンネル開口剤としての新規ベンゾピラン誘導体
|
|
JP4843040B2
(ja)
|
2005-09-15 |
2011-12-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
肝カルニチンパルミトイルトランスフェラーゼのインヒビターとして有用な新規ヘテロ二環式誘導体
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
AU2007214594B2
(en)
|
2006-02-13 |
2010-11-11 |
F. Hoffmann-La Roche Ag |
Heterobicyclic sulfonamide derivatives for the treatment of diabetes
|
|
KR101411695B1
(ko)
|
2006-02-17 |
2014-07-03 |
리겔 파마슈티칼스, 인크. |
자가면역 질환의 치료 또는 예방을 위한 2,4-피리미딘디아민 화합물
|
|
CA2643337C
(en)
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
CA2646093A1
(en)
|
2006-04-06 |
2007-10-11 |
Tibotec Pharmaceuticals Ltd. |
A homogeneous time resolved fluorescence based test system
|
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
US20080305169A1
(en)
|
2006-05-26 |
2008-12-11 |
Japan Tobacco Inc. |
Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
|
|
EP2029550A2
(en)
|
2006-06-01 |
2009-03-04 |
Wyeth a Corporation of the State of Delaware |
1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands
|
|
WO2008003703A1
(en)
|
2006-07-03 |
2008-01-10 |
Biovitrum Ab (Publ) |
Indoles as 5-ht6 modulators
|
|
EP2038301A4
(en)
|
2006-07-12 |
2010-01-20 |
Oncotx Inc |
COMPOSITIONS AND METHODS OF TARGETING CANCER-SPECIFIC TRANSCRIPTION COMPLEXES
|
|
TWI315304B
(en)
|
2006-08-31 |
2009-10-01 |
Univ Taipei Medical |
Indoline-sulfonamides compounds
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
WO2008045664A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
WO2008062740A1
(fr)
|
2006-11-20 |
2008-05-29 |
Japan Tobacco Inc. |
Composé azoté à anneaux fusionnés et son utilisation
|
|
US7799933B2
(en)
|
2006-12-21 |
2010-09-21 |
Hoffman-La Roche Inc. |
Sulfonamide derivatives
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
EP2154965A4
(en)
|
2007-05-29 |
2011-08-17 |
Glaxosmithkline Llc |
NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS
|
|
EP2158327B1
(en)
|
2007-06-03 |
2013-05-15 |
Oncotx, Inc. |
Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
EP2197876A1
(en)
|
2007-08-29 |
2010-06-23 |
Glaxosmithkline LLC |
Thiazole and oxazole kinase inhibitors
|
|
US7960376B2
(en)
|
2007-09-14 |
2011-06-14 |
Cara Therapeutics, Inc. |
Benzo-fused heterocycles
|
|
WO2009040789A2
(en)
|
2007-09-24 |
2009-04-02 |
Technion Research & Development Foundation Ltd. |
T cell subpopulations capable of treating cancer
|
|
US20090131523A1
(en)
|
2007-10-15 |
2009-05-21 |
Enzymotec Ltd. |
Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis
|
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
US7960377B2
(en)
|
2008-03-28 |
2011-06-14 |
Cara Therapeutics, Inc. |
Substituted pyridoxazines
|
|
EP2280946B1
(en)
|
2008-06-05 |
2016-02-10 |
Glaxo Group Limited |
4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
|
|
WO2009147190A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
WO2009149819A1
(en)
|
2008-06-09 |
2009-12-17 |
Sanofi-Aventis |
Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
|
NZ589694A
(en)
|
2008-06-09 |
2012-05-25 |
Sanofi Aventis |
Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
|
|
EP2298731A4
(en)
|
2008-06-25 |
2011-09-21 |
Takeda Pharmaceutical |
AMIDE COMPOUND
|
|
ES2582575T3
(es)
|
2008-07-09 |
2016-09-13 |
Nissan Chemical Industries, Ltd. |
Procedimiento para la producción de compuesto de amida del ácido benzoico sustituido con isoxazolina
|
|
WO2010017827A1
(en)
|
2008-08-14 |
2010-02-18 |
European Molecular Biology Laboratory |
6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases
|
|
EP2321407A4
(en)
|
2008-09-11 |
2012-07-18 |
Univ Florida |
SYSTEM AND METHOD FOR THE PRODUCTION OF T-CELLS
|
|
SI2344471T1
(sl)
|
2008-10-02 |
2013-11-29 |
Taisho Pharmaceutical Co., Ltd. |
Derivat 7-piperidinoalkil-3,4-dihidrokvinolona
|
|
EP2181710A1
(en)
|
2008-10-28 |
2010-05-05 |
Phenex Pharmaceuticals AG |
Ligands for modulation of orphan receptor-gamma (NR1F3) activity
|
|
WO2010057101A2
(en)
|
2008-11-17 |
2010-05-20 |
Schering Corporation |
Compounds useful as hiv blockers
|
|
EP2367598B1
(en)
|
2008-11-19 |
2014-04-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of diacylglycerol acyltransferase
|
|
CN102272153B
(zh)
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
|
CN102388054B
(zh)
|
2008-12-19 |
2015-03-04 |
西特里斯药业公司 |
噻唑并吡啶沉默调节蛋白调节剂的化合物
|
|
TW201030007A
(en)
|
2009-02-06 |
2010-08-16 |
Gruenenthal Gmbh |
Substituted spiro-amides as b1r modulators
|
|
US8524751B2
(en)
|
2009-03-09 |
2013-09-03 |
GlaxoSmithKline Intellecutual Property Development |
4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
|
|
TW201102391A
(en)
|
2009-03-31 |
2011-01-16 |
Biogen Idec Inc |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
|
RS53830B1
(sr)
|
2009-04-30 |
2015-06-30 |
Glaxo Group Limited |
Indazoli supstituisani oksazolom kao inhibitori pi3-kinaze
|
|
ES2586837T3
(es)
|
2009-08-03 |
2016-10-19 |
University Of Miami |
Método para la expansión in vivo de linfocitos T reguladores
|
|
US8119683B2
(en)
|
2009-08-10 |
2012-02-21 |
Taipei Medical University |
Aryl substituted sulfonamide compounds and their use as anticancer agents
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
EP2947073B1
(en)
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
WO2011059839A1
(en)
|
2009-10-29 |
2011-05-19 |
Sirtris Pharmaceuticals, Inc. |
Bicyclic pyridines and analogs as sirtuin modulators
|
|
EP2507231A1
(en)
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
US8956860B2
(en)
|
2009-12-08 |
2015-02-17 |
Juan F. Vera |
Methods of cell culture for adoptive cell therapy
|
|
US20110142814A1
(en)
|
2009-12-16 |
2011-06-16 |
New York University |
Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy
|
|
CA2791738C
(en)
|
2010-03-01 |
2020-06-09 |
Gtx, Inc. |
Aryl imidazolyl compounds for the treatment of cancer
|
|
US8993524B2
(en)
|
2010-03-05 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
WO2011115892A1
(en)
|
2010-03-15 |
2011-09-22 |
Griffin Patrick R |
Modulators of the retinoic acid receptor-related orphan receptors
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201013443D0
(en)
|
2010-08-11 |
2010-09-22 |
Cytovac As |
Compositions and methods for producing dendritic cells
|
|
EP2613781B1
(en)
|
2010-09-08 |
2016-08-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
HRP20151017T1
(hr)
|
2010-09-08 |
2015-10-23 |
Glaxosmithkline Intellectual Property Development Limited |
Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2-(metiloksi)-3-piridinil]metansulfonamida
|
|
WO2012037108A1
(en)
|
2010-09-13 |
2012-03-22 |
Glaxosmithkline Llc |
Aminoquinoline derivatives as antiviral agents
|
|
JP6063870B2
(ja)
*
|
2010-11-08 |
2017-01-18 |
ライセラ・コーポレイション |
ＲＯＲγ活性の阻害用のＮ−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
US9629910B2
(en)
|
2011-03-22 |
2017-04-25 |
The Brigham And Women's Hospital, Inc. |
Use of Th9 cells and IL-9 for the treatment of melanoma
|
|
WO2012127464A2
(en)
|
2011-03-23 |
2012-09-27 |
Gavish-Galilee Bio Applications Ltd |
Constitutively activated t cells for use in adoptive cell therapy
|
|
WO2012129514A1
(en)
|
2011-03-23 |
2012-09-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
|
CN111298120A
(zh)
|
2011-06-24 |
2020-06-19 |
格里生物公司 |
炎性病症的预防和治疗
|
|
PT2758060T
(pt)
|
2011-09-19 |
2018-01-24 |
ETH Zürich |
Moduladores de ror gama para o tratamento de complicações de diabetes ii
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
EP2825197B1
(en)
|
2012-03-16 |
2018-06-06 |
Covagen AG |
Novel binding molecules with antitumoral activity
|
|
WO2013167136A1
(en)
|
2012-05-08 |
2013-11-14 |
Herlev Hospital |
Improving adoptive cell therapy with interferon gamma
|
|
EP2847198B1
(en)
|
2012-05-08 |
2016-12-14 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease
|
|
RU2014149136A
(ru)
|
2012-05-08 |
2016-07-10 |
Мерк Шарп И Доум Корп. |
ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ
|
|
CA2871504C
(en)
|
2012-05-08 |
2020-07-21 |
Merck Sharp & Dohme Corp. |
Bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of disease
|
|
JP6220388B2
(ja)
|
2012-05-25 |
2017-10-25 |
ヘルス・ダイアグノスティック・ラボラトリー，インコーポレーテッド |
ステロール／スタノール又はそれらの誘導体の迅速でハイスループットの分析
|
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
|
PL3489261T3
(pl)
|
2012-08-24 |
2021-08-16 |
The Regents Of The University Of California |
Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
|
|
EP2931267A1
(en)
|
2012-12-17 |
2015-10-21 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical compositions for the treatment of x-linked charcot-marie-tooth
|
|
WO2014201378A1
(en)
|
2013-06-13 |
2014-12-18 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with extended-pk il -2 and adoptive cell therapy
|
|
WO2015095792A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
|
|
WO2015095788A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
|
WO2015095795A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE, AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
|
AU2015222917A1
(en)
|
2014-02-27 |
2016-09-15 |
Lycera Corporation |
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
|
|
WO2015171558A2
(en)
|
2014-05-05 |
2015-11-12 |
Lycera Corporation |
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
|
|
EP3140291A4
(en)
|
2014-05-05 |
2018-01-10 |
Lycera Corporation |
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
|
|
WO2016179343A1
(en)
|
2015-05-05 |
2016-11-10 |
Lycera Corporation |
DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
|